136 related articles for article (PubMed ID: 24990632)
1. Predictive factors and pattern of locoregional recurrence after prophylactic central neck dissection in papillary thyroid carcinoma.
Lang BH; Chan DT; Wong KP; Wong KK; Wan KY
Ann Surg Oncol; 2014 Dec; 21(13):4181-7. PubMed ID: 24990632
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Prophylactic Central Neck Dissection on Locoregional Recurrence in Papillary Thyroid Cancer After Total Thyroidectomy: A Systematic Review and Meta-Analysis : pCND for the Locoregional Recurrence of Papillary Thyroid Cancer.
Zhao W; You L; Hou X; Chen S; Ren X; Chen G; Zhao Y
Ann Surg Oncol; 2017 Aug; 24(8):2189-2198. PubMed ID: 27913945
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy.
Lang BH; Ng SH; Lau LL; Cowling BJ; Wong KP; Wan KY
Thyroid; 2013 Sep; 23(9):1087-98. PubMed ID: 23402640
[TBL] [Abstract][Full Text] [Related]
4. A cost-utility analysis for prophylactic central neck dissection in clinically nodal-negative papillary thyroid carcinoma.
Wong CK; Lang BH
Ann Surg Oncol; 2014 Mar; 21(3):767-77. PubMed ID: 24276639
[TBL] [Abstract][Full Text] [Related]
5. A cost-minimization analysis comparing total thyroidectomy alone and total thyroidectomy with prophylactic central neck dissection in clinically nodal-negative papillary thyroid carcinoma.
Lang BH; Wong CK
Ann Surg Oncol; 2014 Feb; 21(2):416-25. PubMed ID: 23982258
[TBL] [Abstract][Full Text] [Related]
6. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
7. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
8. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the effectiveness of prophylactic central neck dissection with total thyroidectomy for cN0 papillary thyroid carcinoma: An updated meta-analysis.
Zhao WJ; Luo H; Zhou YM; Dai WY; Zhu JQ
Eur J Surg Oncol; 2017 Nov; 43(11):1989-2000. PubMed ID: 28807633
[TBL] [Abstract][Full Text] [Related]
10. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
11. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
14. Optimal extent of prophylactic central neck dissection for papillary thyroid carcinoma: Comparison of unilateral versus bilateral central neck dissection.
Yoo HS; Shin MC; Ji YB; Song CM; Lee SH; Tae K
Asian J Surg; 2018 Jul; 41(4):363-369. PubMed ID: 28454667
[TBL] [Abstract][Full Text] [Related]
15. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.
Lang BH; Wong KP; Wan KY; Lo CY
Ann Surg Oncol; 2012 Jan; 19(1):60-7. PubMed ID: 21681379
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis.
Zetoune T; Keutgen X; Buitrago D; Aldailami H; Shao H; Mazumdar M; Fahey TJ; Zarnegar R
Ann Surg Oncol; 2010 Dec; 17(12):3287-93. PubMed ID: 20596784
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Central Neck Dissection Might Not Be Necessary in Papillary Thyroid Carcinoma: Analysis of 11,569 Cases from a Single Institution.
Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
J Am Coll Surg; 2016 May; 222(5):853-64. PubMed ID: 27113516
[TBL] [Abstract][Full Text] [Related]
18. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence.
Roh JL; Kim JM; Park CI
Ann Surg Oncol; 2011 Aug; 18(8):2245-50. PubMed ID: 21327454
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic central neck dissection has no advantage in patients with metastatic papillary thyroid cancer to the lateral neck.
Carmel-Neiderman NN; Mizrachi A; Yaniv D; Vainer I; Muhanna N; Abergel A; Izhakov E; Robenshtok E; Warshavsky A; Ringel B; Ungar OJ; Bachar G; Shpitzer T; Hirsch D; Fliss DM; Horowitz G
J Surg Oncol; 2021 Feb; 123(2):456-461. PubMed ID: 33259678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
